Scott Marsh Financial’s LeMaitre Vascular LMAT Stock Holding History

Scott Marsh Financial’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$581K	Buy	+7,001	New	+$585K	0.22%	142

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Scott Marsh Financial's LMAT Position: Q2 2025 in Review

Scott Marsh Financial opened a new position in LeMaitre Vascular (LMAT) in Q2 2025: 7,001 shares worth $581K. The stake represents 0.22% of the portfolio and ranks #142 among its holdings.

283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

Scott Marsh Financial held 7,001 shares of LeMaitre Vascular worth $581K as of Q2 2025.
LeMaitre Vascular was a new Scott Marsh Financial position in Q2 2025.
LeMaitre Vascular made up 0.22% of Scott Marsh Financial's portfolio in Q2 2025, its #142 holding.
283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on Scott Marsh Financial's 13F filing for Q2 2025, filed 14 Aug 2025.